Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Protoivpump inhibitors for gastric acid-related disease
    Thomas G. Franko, MS and Joel E. Richter, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 27-34;

    Proton-pump inhibitors are the most effective drugs for suppressing gastric acid production. Concerns over potential ill effects of hypergastrinemia have proved unfounded.

  • You have access
    Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 8;
  • You have access
    New guidelines streamline diabetes diagnosis
    S. Sethu K. Reddy, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 10-12;

    Recent changes in the screening guidelines for diabetes should simplify the diagnostic process and identify more people who are at risk.

  • You have access
    Anorectic drugs and valvular heart disease: A biological and clinical perspective
    James Wong, MD, PHD, S. Sethu K. Reddy, MD and Allan L. Klein, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 35-41;

    The echocardiography appearance of valvular lesions associated with the use of fenfluramine and dexfenfluramine, and current suggestions on how to follow patients who took these drugs.

  • You have access
    Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 508;
  • You have access
    Homocysteine: Update on a new risk factor
    Raj S. Ballal, MD, Donald W. Jacobsen, PHD and Killian Robinson, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 543-549;

    A high fasting plasma homocysteine level is an independent risk factor for atherosclerosis and venous thrombosis.

  • You have access
    Stereotactic breast biopsy: A less-invasive option
    William A. Chilcote, MD and Christine A. Quinn, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 550-554;

    Percutaneous core needle biopsy, guided by digital three-dimensional x-ray imaging, offers a reasonable alternative to standard surgical biopsy.

  • You have access
    Index to Volume 64
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 555-558;
  • You have access
    1997 Reviewers
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 519;
  • You have access
    Stress ulcer prophylaxis: The case for a selective approach
    Mary Beth Bobek, PharmD and Alejandro C. Arroliga, MD
    Cleveland Clinic Journal of Medicine November 1997, 64 (10) 533-542;

    Although stress-related mucosal damage is common in critically ill patients, the risk of significant gastrointestinal bleeding appears to be confined to patients with certain risk factors. A full-color illustration explaining the pathogenesis of stress-related mucosal damage accompanies this article.

Pages

  • Previous
  • Next
  • 1
  • …
  • 444
  • 445
  • 446
  • 447
  • 448
  • 449
  • 450
  • 451
  • 452
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire